Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of oral dydrogesterone and 17α-hydroxyprogesterone caproate in prevention of preterm birth after preterm labor
IRCT20181207041879N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dydrogesterone and hydroxyprogesterone caproate in Preterm labor (PTL) and preterm birth (2 arms), sponsored by Mashhad University of Medical Sciences. Started Oct 2018; status: completed.
02
Drugs
dydrogesteronehydroxyprogesterone caproate
03
Conditions
Preterm labor (PTL)preterm birth
Beyond the preview
Go deeper on IRCT20181207041879N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181207041879N1.